Straumann Holding AG
SIX:STMN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Comtech Telecommunications Corp
NASDAQ:CMTL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (29.6), the stock would be worth CHf121.72 (38% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 21.4 | CHf88.14 |
0%
|
| 3-Year Average | 29.6 | CHf121.72 |
+38%
|
| 5-Year Average | 33.7 | CHf138.7 |
+57%
|
| Industry Average | 24.1 | CHf99.09 |
+12%
|
| Country Average | 19.5 | CHf80.38 |
-9%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
CHf14.3B
|
/ |
Jan 2026
CHf654.6m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2026
CHf665.8m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2027
CHf757.2m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2028
CHf853.1m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
|
Straumann Holding AG
SIX:STMN
|
14.2B CHF | 21.4 | 39.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161B USD | 19 | 25.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.3B USD | 56.5 | 60.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 24.1 | 38.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.2B USD | 18.7 | 23.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.3B USD | 26.3 | 33 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.6B EUR | 15.6 | 19.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 26.3 | 44 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 33.9 | 43.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 16.8 | 25.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.9B USD | 13.6 | 15.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.5 |
| Median | 19.5 |
| 70th Percentile | 25.3 |
| Max | 855.5 |
Other Multiples
Straumann Holding AG
Glance View
Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale. The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.